ID: 85: CROSS-TALK BETWEEN ESTROGEN RECEPTORS AND INSULIN-LIKE GROWTH FACTOR TYPE-1 RECEPTOR MODULATES HUMAN PROSTATE STEM/PROGENITOR CELL AMPLIFICATION. Issue 4 (22nd March 2016)
- Record Type:
- Journal Article
- Title:
- ID: 85: CROSS-TALK BETWEEN ESTROGEN RECEPTORS AND INSULIN-LIKE GROWTH FACTOR TYPE-1 RECEPTOR MODULATES HUMAN PROSTATE STEM/PROGENITOR CELL AMPLIFICATION. Issue 4 (22nd March 2016)
- Main Title:
- ID: 85: CROSS-TALK BETWEEN ESTROGEN RECEPTORS AND INSULIN-LIKE GROWTH FACTOR TYPE-1 RECEPTOR MODULATES HUMAN PROSTATE STEM/PROGENITOR CELL AMPLIFICATION
- Authors:
- Rinaldi, JD
Hu, W
Majundar, S
Hu, D
Prins, GS
Justulin, L
Felisbino, SL - Abstract:
- Abstract : We previously demonstrated that estrogen regulates human prostate stem/progenitor cell amplification by directly targeting estrogen receptors (ERs); ERα stimulates whereas ERβ suppresses stem cell self-renewal. In addition to ERα and ERβ, we find that human prostate stem/progenitor cells express robust level of IGF-1R. Since ER actions can be modified by IGF-1R through ligand-independent ER phosphorylation, we herein sought to characterize potential cross-talk between estrogen and IGF-1 signaling pathways in regulating human prostate stem/progenitor cell amplification. Human prostate stem/progenitor cells were isolated from normal primary prostate epithelial cells (PrEC) using 3-D prostasphere (PS) culture. Similar to estradiol-17β (E2 ), 5 nM IGF-1 treatment increased the number of PS as well as long-term BrdU-retaining prostate stem cells. Conversely, knockdown of IGF-1R by siRNA decreased both parameters and consistently increased PS ERβ expression. Together these findings suggest that IGF-1R activation may drive prostate stem cell amplification through suppression of ERβ. Further studies revealed that E2 (10 nM) exposure induced IGF-1R phosphorylation while IGF-1R knockdown inhibited the non-genomic E2 -induced pAkt and pERK confirming the cross-talk between these two signaling pathways. IGF-1R knockdown decreased PHLDA1, a known IGF-1 target gene, inhibited E2 -induced ERα phosphorylation, suggesting a positive interaction between IGF-1R and ERα. In summary,Abstract : We previously demonstrated that estrogen regulates human prostate stem/progenitor cell amplification by directly targeting estrogen receptors (ERs); ERα stimulates whereas ERβ suppresses stem cell self-renewal. In addition to ERα and ERβ, we find that human prostate stem/progenitor cells express robust level of IGF-1R. Since ER actions can be modified by IGF-1R through ligand-independent ER phosphorylation, we herein sought to characterize potential cross-talk between estrogen and IGF-1 signaling pathways in regulating human prostate stem/progenitor cell amplification. Human prostate stem/progenitor cells were isolated from normal primary prostate epithelial cells (PrEC) using 3-D prostasphere (PS) culture. Similar to estradiol-17β (E2 ), 5 nM IGF-1 treatment increased the number of PS as well as long-term BrdU-retaining prostate stem cells. Conversely, knockdown of IGF-1R by siRNA decreased both parameters and consistently increased PS ERβ expression. Together these findings suggest that IGF-1R activation may drive prostate stem cell amplification through suppression of ERβ. Further studies revealed that E2 (10 nM) exposure induced IGF-1R phosphorylation while IGF-1R knockdown inhibited the non-genomic E2 -induced pAkt and pERK confirming the cross-talk between these two signaling pathways. IGF-1R knockdown decreased PHLDA1, a known IGF-1 target gene, inhibited E2 -induced ERα phosphorylation, suggesting a positive interaction between IGF-1R and ERα. In summary, the present results document robust crosstalk between estrogen and IGF-1 signaling which together regulate their downstream signal molecules including pAKT/pERK and PHLDA1. We propose that these pathways coordinately modulate prostate stem and progenitor cell numbers to effectively maintain glandular homeostasis. Supported by NIH/NCI award R01 CA172220; scholarship by FAPESP grant#2014/10965-6. … (more)
- Is Part Of:
- Journal of investigative medicine. Volume 64:Issue 4(2016)
- Journal:
- Journal of investigative medicine
- Issue:
- Volume 64:Issue 4(2016)
- Issue Display:
- Volume 64, Issue 4 (2016)
- Year:
- 2016
- Volume:
- 64
- Issue:
- 4
- Issue Sort Value:
- 2016-0064-0004-0000
- Page Start:
- 929
- Page End:
- 929
- Publication Date:
- 2016-03-22
- Subjects:
- Abdomen
Clinical medicine -- Periodicals
Medicine -- Research -- Periodicals
Medicine
Research -- United States
Clinical medicine
Medicine -- Research
Periodicals
616.075 - Journal URLs:
- http://journals.lww.com/jinvestigativemed/pages/default.aspx ↗
http://jim.bmj.com/ ↗
https://journals.sagepub.com/home/IMJ ↗
http://journals.lww.com ↗ - DOI:
- 10.1136/jim-2016-000120.38 ↗
- Languages:
- English
- ISSNs:
- 1081-5589
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5008.010000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 23710.xml